Max Augustin

4.3k citations
29 papers · 389 indexed · h-index 10
Topics
SARS-CoV-2 and COVID-19 Research (10 papers)COVID-19 Clinical Research Studies (8 papers)Long-Term Effects of COVID-19 (8 papers)
Partner nations
GermanyFranceAustria

In The Last Decade

Max Augustin

24 papers receiving 380 citations

Peers

Max Augustin
Comparison fields: 5 of 85
  • Infectious Diseases 148
  • Neurology 114
  • Sensory Systems 65
  • Biomedical Engineering 54
  • Epidemiology 47
Replace Zhiyong Dai with:
Zhiyong Dai China
Antonello Serra Italy
Roberto Lovero Italy
Sharon Ovnat Tamir Israel
Mary John India
Pierre‐Yves Royer France
José Luis Cortes-Cuevas Spain
Puya Dehgani‐Mobaraki Italy
Mohnish Grover India
M. K. Sen India
Max Augustin relative to Zhiyong Dai China Zhiyong Dai's profile →
Citations per field
00.5×
Zhiyong Dai · 1×
Citations per year

Countries citing papers authored by Max Augustin

Since Specialization
Citations

This map shows the geographic impact of Max Augustin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Augustin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Augustin more than expected).

Fields of papers citing papers by Max Augustin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Augustin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Augustin. The network helps show where Max Augustin may publish in the future.

Co-authorship network of co-authors of Max Augustin

This figure shows the co-authorship network connecting the top 25 collaborators of Max Augustin. A scholar is included among the top collaborators of Max Augustin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Augustin. Max Augustin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 20
3 0
4 46
5 5
6 10
7 9
8 3
9 0
10 0
11 1
12 5
13 10
14 2
15 23
16 120
17 3
18 27
19 55
20
[ANORCHIDISM WITH NORMAL XY KARYOTYPE].
0

About Max Augustin

Max Augustin is a scholar working on Infectious Diseases, Virology and Neurology, having authored 29 papers that have together received 389 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (8 papers) and Long-Term Effects of COVID-19 (8 papers). The work is most often cited by research in Sensory Systems (65 citations), Infectious Diseases (148 citations) and Neurology (114 citations). Max Augustin has collaborated with scholars based in Germany, France and Austria. Frequent co-authors include Florian Klein, Clara Lehmann, Felix Dewald, Niklas Loreck, Philomena A. Wawer Matos, Alexander C. Rokohl, Ludwig M. Heindl, Jan-Christoffer Lüers, Michael Koller and Beate Wieseler. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026